High inorganic phosphate concentration inhibits osteoclastogenesis by modulating miR-223
- PMID: 26255635
- DOI: 10.1016/j.bbadis.2015.08.003
High inorganic phosphate concentration inhibits osteoclastogenesis by modulating miR-223
Abstract
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a common complication of CKD, and uremic toxins have been shown to be instrumental in this process. We have previously shown that miR-223 is increased in smooth muscle cells subjected to the uremic toxin inorganic phosphate (Pi). In the present study we investigated the influence of this miRNA in osteoclastogenesis in order to elucidate its role in the course of CKD-MBD. RT-qPCR demonstrated that high Pi concentration decreased miR-223 expression in differentiated RAW 264.7 cells. Up- and down-regulation of miR-223 was performed using specific pre-miR and anti-miR-223. Differentiation of monocyte/macrophage precursors was assessed by using RAW 264.7 cells and peripheral blood mononuclear cells (PBMC). TRAP activity and bone resorption were used to measure osteoclast activity. Pi induced a marked decrease in osteoclastogenesis in RAW cells and miR-223 levels were concomitantly decreased. Anti-miR-223 treatment inhibited osteoclastogenesis in the same way as Pi. In contrast, overexpression of miR-223 triggered differentiation, as reflected by TRAP activity. We showed that miR-223 affected the expression of its target genes NFIA and RhoB, but also osteoclast marker genes and the Akt signalling pathway, which induces osteoclastogenesis. These results were confirmed by measuring bone resorption activity of human PBMC differentiated into osteoclasts. We thus demonstrate a role of miR-223 in osteoclast differentiation, with rational grounds to use deregulation of this miRNA to selectively increase osteoclast-like activity in calcified vessels of CKD-MBD. This approach could alleviate vascular calcification without altering bone structure.
Keywords: Calcification; Cell differentiation; MicroRNA (miRNA); Osteoclast; Vascular; miR-223.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.RNA Biol. 2015;12(3):343-53. doi: 10.1080/15476286.2015.1017205. RNA Biol. 2015. PMID: 25826666 Free PMC article.
-
miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases.Exp Cell Res. 2015 Oct 15;338(1):89-96. doi: 10.1016/j.yexcr.2015.07.023. Epub 2015 Jul 26. Exp Cell Res. 2015. PMID: 26216483
-
Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation.Mod Rheumatol. 2013 Jul;23(4):674-85. doi: 10.1007/s10165-012-0710-1. Epub 2012 Aug 19. Mod Rheumatol. 2013. PMID: 22903258
-
Inorganic phosphate-induced impairment of osteoclast cell-cell fusion by the inhibition of AP-1-mediated DC-STAMP expression.Biochem Biophys Res Commun. 2017 Nov 4;493(1):9-13. doi: 10.1016/j.bbrc.2017.09.096. Epub 2017 Sep 20. Biochem Biophys Res Commun. 2017. PMID: 28939042
-
microRNAs in the pathophysiology of CKD-MBD: Biomarkers and innovative drugs.Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):337-345. doi: 10.1016/j.bbadis.2016.10.027. Epub 2016 Oct 30. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27806914 Review.
Cited by
-
Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients.Nephrol Dial Transplant. 2024 Mar 27;39(4):618-626. doi: 10.1093/ndt/gfad190. Nephrol Dial Transplant. 2024. PMID: 37660283 Free PMC article.
-
MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease.Clin Kidney J. 2022 Oct 7;16(3):408-421. doi: 10.1093/ckj/sfac219. eCollection 2023 Mar. Clin Kidney J. 2022. PMID: 36865016 Free PMC article. Review.
-
A New Method to Sort Differentiating Osteoclasts into Defined Homogeneous Subgroups.Cells. 2022 Dec 8;11(24):3973. doi: 10.3390/cells11243973. Cells. 2022. PMID: 36552735 Free PMC article.
-
Analysis of miRNA Associated with Coronary Artery Calcification.Comput Math Methods Med. 2022 Jul 25;2022:3708547. doi: 10.1155/2022/3708547. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Nov 29;2023:9801792. doi: 10.1155/2023/9801792. PMID: 35924109 Free PMC article. Retracted.
-
Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?Toxins (Basel). 2022 Apr 14;14(4):280. doi: 10.3390/toxins14040280. Toxins (Basel). 2022. PMID: 35448889 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous